Exact Sciences (EXAS) PT Lowered to $15 at Roth Capital, Recommends Buying on Weakness
Tweet Send to a Friend
Roth Capital analyst Chris Lewis lowered his price target on Exact Sciences (NASDAQ: EXAS) to $15.00 (from $31.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
